Publications by authors named "Stella Garcia Colombarolli"

Phage display is a molecular biology cloning technique that allows the expression of genes of interest along with the phage surface protein. The technique described for the following method used a genomic library for the expression of peptides composed of 12 amino acids, with the objective of selecting peptides which presented specific affinity to the molecules of interest. As a target, purified extracellular vesicles from cell cultures of cells 5637 and RT4 were chosen, which in turn have enormous application and can help to understand the functioning of bladder cancer, allowing the development of new vaccines, drugs, therapies, and diagnoses.

View Article and Find Full Text PDF

Flavivirus are the most alarming prevalent viruses worldwide due to its vast impact on public health. Most early symptoms of diseases caused by Flavivirus are similar among each other and to other febrile illnesses making the clinical differential diagnosis challenging. In addition, due to cross-reactivity and a relatively limited persistence of viral RNA in infected individuals, the current available diagnosis strategies fail to efficiently provide a differential viral identification.

View Article and Find Full Text PDF
Article Synopsis
  • Yellow Fever is caused by the Yellow Fever Virus (YFV), which has re-emerged due to urbanization, widespread mosquitoes, and low vaccination rates in the Americas, leading to severe outbreaks with high mortality rates.
  • Researchers developed serological methods to differentiate between antibodies from wild-type YFV infections and those from vaccinated individuals using the YFV-17DD strain.
  • In a study during the 2017/2018 Brazilian outbreak, ten promising peptides were identified that could help in differentiating between vaccinated and naturally infected individuals, with one peptide successfully synthesized and validated through ELISA testing.
View Article and Find Full Text PDF

Dengue virus (DENV) is a Flavivirus estimated to cause 390 million infections/year. Currently, there is no anti-viral specific treatment for dengue, and efficient DENV vector control is still unfeasible. Here, we designed and produced chimeric proteins containing potential immunogenic epitopes from the four DENV serotypes in an attempt to further compose safer, balanced tetravalent dengue vaccines.

View Article and Find Full Text PDF